Mydecine Innovations Group Inc.
Psychedelic-assisted therapy platform and psilocybin-based therapeutics
- Sector
- Biotech
- Headquarters
- VANCOUVER, A1
- Latest Form D
- $628K, Jun 2022
- Total capital
- $628K
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $628K
- 1 Form D · last Jun 2022
- 52 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 1
- first 2026
- Rank in peer group#481 of 1449
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 1st filing$628K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 1449 peers
Line = medianBiotech · Molecule
- Granted patents#481 · top 33%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Dr. Saeid BabaeiDirectorNamed in SEC Form D filings
- Joshua BartchDirector, Executive OfficerNamed in SEC Form D filings
- Dean DittoExecutive OfficerNamed in SEC Form D filings
- Dr. Victoria HaleDirectorNamed in SEC Form D filings
- Dr. Rakesh JetlyExecutive OfficerNamed in SEC Form D filings
- Damon MichaelsDirector, Executive OfficerNamed in SEC Form D filings
Show all 10 people
- Gordon NealDirectorNamed in SEC Form D filings
- Robert RoscowDirector, Executive OfficerNamed in SEC Form D filings
- Sanford SteinExecutive OfficerNamed in SEC Form D filings
- Josephine WuDirectorNamed in SEC Form D filings
What it has protected
USPTO · 1 granted of 1- New patentNovel Psilocin Analog Compositions And Methods of Synthesizing The SameUSPTOUS 12,759,978
Related companies, and why
- ENGEN BIO, LLCSimilar federal contract value in Biotech · null in contracts
- Embold Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
- OPTIGENEX INC.Similar federal contract value in Biotech · null in contracts
- Parnell Pharmaceuticals Holdings LtdSimilar federal contract value in Biotech · null in contracts
- Intervene Immune, Inc.Similar federal contract value in Biotech · null in contracts
- LongRun P.B.C.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .